Cancer drug tested in hunt for HIV's brain hideout
NCT ID NCT03239899
Summary
This small, early-stage study tested whether a single dose of the cancer drug pembrolizumab is safe for people with well-controlled HIV. The main goal was to check for safety, not to treat HIV. Researchers also wanted to see if the drug could help reveal if the virus was hiding in the brain, which might be important for future research toward a cure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.